HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 185 filers reported holding HORIZON PHARMA PLC in Q4 2017. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $22,139,000 | +25.3% | 837,629 | -7.3% | 0.03% | +17.9% |
Q4 2018 | $17,666,000 | +36.0% | 904,045 | +36.2% | 0.03% | +75.0% |
Q3 2018 | $12,994,000 | +669.3% | 663,587 | +550.7% | 0.02% | +700.0% |
Q2 2018 | $1,689,000 | -89.4% | 101,973 | -90.9% | 0.00% | -90.5% |
Q1 2018 | $15,967,000 | +288.3% | 1,124,465 | +299.2% | 0.02% | +250.0% |
Q4 2017 | $4,112,000 | +1606.2% | 281,651 | +1380.4% | 0.01% | – |
Q3 2017 | $241,000 | -92.3% | 19,025 | -90.2% | 0.00% | -100.0% |
Q4 2016 | $3,148,000 | -59.8% | 194,569 | -55.0% | 0.01% | -53.8% |
Q3 2016 | $7,839,000 | +215.8% | 432,367 | +187.0% | 0.01% | +116.7% |
Q2 2016 | $2,482,000 | +224.9% | 150,675 | +226.6% | 0.01% | +200.0% |
Q1 2016 | $764,000 | -86.1% | 46,131 | -81.8% | 0.00% | -83.3% |
Q4 2015 | $5,499,000 | +50.4% | 253,763 | +37.5% | 0.01% | +71.4% |
Q3 2015 | $3,657,000 | -80.7% | 184,510 | -66.1% | 0.01% | -80.6% |
Q2 2015 | $18,906,000 | +135.5% | 544,211 | +76.1% | 0.04% | +140.0% |
Q1 2015 | $8,028,000 | +91.8% | 309,108 | -9.3% | 0.02% | +36.4% |
Q3 2014 | $4,185,000 | – | 340,825 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JABODON PT CO | 187,808 | $4,519,000 | 3.52% |
KNOTT DAVID M | 50,046 | $1,204,000 | 0.51% |
CASTLEARK MANAGEMENT LLC | 362,980 | $8,733,000 | 0.34% |
EAGLE ASSET MANAGEMENT INC | 2,692,100 | $64,771,000 | 0.33% |
USA FINANCIAL FORMULAS | 15,202 | $402,000 | 0.20% |
Qtron Investments LLC | 12,274 | $295,000 | 0.18% |
C WorldWide Group Holding A/S | 491,544 | $11,827,000 | 0.15% |
Gotham Asset Management, LLC | 207,158 | $4,984,000 | 0.08% |
Russell Investments Group, Ltd. | 608,977 | $14,652,000 | 0.03% |
FNY Investment Advisers, LLC | 3,350 | $80,000 | 0.02% |